Lack of CD8+ T cell effector differentiation during priming mediates checkpoint blockade resistance in non-small cell lung cancer.
Brendan L HortonDuncan M MorganNoor MominMaria ZagorulyaElen Torres-MejiaVidit BhandarkarKarl Dane WittrupJohn Christopher LoveStefani SprangerPublished in: Science immunology (2021)
[Figure: see text].